Patent(s) and the Corresponding Patented Drug(s) |
Top |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US9598431 |
Title |
Compounds useful for inhibiting ROR-gamma-t |
Abstract |
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof: |
Applicant(s) |
Eli Lilly and Company |
Representative Drug(s) |
D0ZX6M |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D09YHB
|
Drug Info
|
N.A.
|
[1] |
3
|
D0A9KU
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US9598431 |
Title |
Compounds useful for inhibiting ROR-gamma-t |
Abstract |
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof: |
Applicant(s) |
Eli Lilly and Company |
Representative Drug(s) |
D0ZX6M |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D09YHB
|
Drug Info
|
N.A.
|
[1] |
3
|
D0A9KU
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US9598431 |
Title |
Compounds useful for inhibiting ROR-gamma-t |
Abstract |
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof: |
Applicant(s) |
Eli Lilly and Company |
Representative Drug(s) |
D0ZX6M |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D09YHB
|
Drug Info
|
N.A.
|
[1] |
3
|
D0A9KU
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US9598431 |
Title |
Compounds useful for inhibiting ROR-gamma-t |
Abstract |
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof: |
Applicant(s) |
Eli Lilly and Company |
Representative Drug(s) |
D0ZX6M |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D09YHB
|
Drug Info
|
N.A.
|
[1] |
3
|
D0A9KU
|
Drug Info
|
N.A.
|
[1] |